Note to the reader This article presents reflections on regulation, language, and responsibility in relation to medication and non-medical systems. It does not provide medical advice and is not intended to diagnose, treat, or replace professional healthcare or medication. Why a Headache Pill Can Promise Relief – and Others Cannot A question often arises in discussions about healthcare communication: Why can a headache pill state that it “relieves pain,” while individual systems and practitioners are not allowed to describe concrete experiences? The answer is not about truth or honesty. It is about regulation, responsibility, and structure. Medication Operates Under a Different Legal Framework When a headache medication uses phrases such as: “relieves headache” “reduces pain” this is permitted because the product: is classified as a medicinal product has been assessed and approved by regulatory authorities is supported by clinical documentation places legal responsibility on the manufac

Note to the reader This article presents reflections and socio-economic considerations regarding evidence, regulation, and healthcare structures. It does not provide medical advice and is not intended to diagnose, treat, or replace professional healthcare or medication. When Evidence Becomes a Privilege – and the Cost Is Paid by Society In public discourse, evidence is often presented as something neutral, objective, and universally accessible. In reality, evidence is expensive, exclusive, and largely available only to those with capital. This is not a marginal issue. It is a structural problem with significant social and economic consequences. Evidence Is Not Neutral – It Is Costly To document a method according to accepted medical or regulatory standards typically requires: large financial investments years of work access to research institutions legal and administrative infrastructure often, a patentable product to justify the cost As a result, only a narrow group of actors can real